Skip to main content
. 2020 Sep 29;10:553045. doi: 10.3389/fonc.2020.553045

Figure 4.

Figure 4

The correlation between HNRNPA2B1 and clinicopathological features. (A) The expression of HNRNPA2B1 in ESCA patients of different tumor histology. (B) The expression of HNRNPA2B1 in ESCA patients of different cancer stage. (C) The expression of HNRNPA2B1 in ESCA patients of different tumor grade. (D) The expression of HNRNPA2B1 in ESCA patients of different gender. (E) The expression of HNRNPA2B1 in ESCA patients of different age. (F) The expression of HNRNPA2B1 in ESCA patients of different weight. *P < 0.05, **P < 0.01, and ***P < 0.001.